Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
LFST gained 7.7% over 21 sessions and closed at a period high on September 10. Revenue grew 16%, free cash flow reached $87.9 million, and management raised adjusted EBITDA guidance on visit growth and productivity improvements.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Margin Improvement ⢠Strong Cash Flow ⢠Liquidity Pressure LFST shows improving quarterly margins and strong cash flow, but historically thin profitability, weakening liquidity, intangible-heavy assets, and a demanding valuation warrant caution.
Price Behavior
Key Price Behavior Insights: ⢠Recent pullback ⢠Support holding ⢠Resistance capped Support Level: $12.15â$12.30 Resistance Level: $13.00â$13.38 LFST is neutral-to-cautious after pulling back 6% from $13.38, with traders watching for a rebound from $12.15â$12.30 support or a breakout above $13.38.
Sentiment & News
Key News Insights: ⢠52-Week High ⢠New Institutional Stakes ⢠Secondary Share Sale LifeStance's strong share momentum and rising institutional interest are tempered by a large secondary sale that adds no new company capital.
AI Summary
LFST has evolved into an operating-leverage and free-cash-flow story, but after its sharp rerating investors should be selective: upside depends on sustaining mid-teen visit growth and expanding margins through the EHR rollout, while any payer, labor, or implementation-driven slowdown could expose a demanding valuation.
Description
LifeStance Health Group, Inc. is a provider of outpatient mental health services delivering psychiatric assessment, psychological and neuropsychological testing, and various therapy modalities across the lifespan. The company treats a broad set of psychiatric conditions and offers care both in-person at centers across 32 states and through a virtual platform. Founded in 2017, LifeStance is headquartered in Scottsdale, Arizona.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Sep 10 | Sep 17 | LFST | LifeStance Health Group, Inc. | LFST gained 7.7% over 21 sessions and closed at a period high on September 10. Revenue grew 16%, free cash flow reached $87.9 million, and management raised adjusted EBITDA guidance on visit growth and productivity improvements. | Closed | -3.0% |